IRIS
CASTAGNA, MARIA GRAZIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.994
NA - Nord America 4.407
AS - Asia 462
AF - Africa 36
OC - Oceania 14
SA - Sud America 7
Continente sconosciuto - Info sul continente non disponibili 4
Totale 9.924
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.395
GB - Regno Unito 1.313
IE - Irlanda 1.154
IT - Italia 964
SE - Svezia 494
CN - Cina 266
UA - Ucraina 252
FR - Francia 221
RU - Federazione Russa 199
DE - Germania 151
FI - Finlandia 112
SG - Singapore 93
ES - Italia 48
CI - Costa d'Avorio 33
IN - India 31
BE - Belgio 22
TR - Turchia 22
IR - Iran 17
AU - Australia 13
CZ - Repubblica Ceca 13
NL - Olanda 13
PL - Polonia 11
VN - Vietnam 11
CA - Canada 9
JP - Giappone 7
BR - Brasile 5
EU - Europa 4
MK - Macedonia 4
RO - Romania 4
AT - Austria 3
CH - Svizzera 2
CR - Costa Rica 2
GR - Grecia 2
IM - Isola di Man 2
IQ - Iraq 2
KZ - Kazakistan 2
LT - Lituania 2
LU - Lussemburgo 2
PH - Filippine 2
SA - Arabia Saudita 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AR - Argentina 1
BO - Bolivia 1
BY - Bielorussia 1
DK - Danimarca 1
EG - Egitto 1
HK - Hong Kong 1
IL - Israele 1
IS - Islanda 1
JM - Giamaica 1
KR - Corea 1
MA - Marocco 1
MT - Malta 1
MY - Malesia 1
NZ - Nuova Zelanda 1
SK - Slovacchia (Repubblica Slovacca) 1
SM - San Marino 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 9.924
Salva come PNG Salva come JPEG
Città #
Southend 1.241
Dublin 1.130
Fairfield 766
Chandler 420
Ashburn 372
Woodbridge 342
Wilmington 293
Houston 276
Seattle 275
Cambridge 268
Ann Arbor 222
Siena 196
Jacksonville 174
Princeton 146
Florence 135
Helsinki 87
San Mateo 69
Moscow 64
Beijing 58
Shanghai 53
Nanjing 49
Singapore 48
New York 39
Rome 39
San Diego 39
Málaga 38
Abidjan 33
Boardman 31
Dearborn 30
Milan 29
Saint Petersburg 29
Brussels 21
London 19
Redwood City 17
Prato 15
Düsseldorf 14
Fremont 13
Izmir 13
Naples 13
Jiaxing 12
Norwalk 12
Bari 11
Dong Ket 11
Nanchang 11
Ponte Buggianese 11
Brno 10
Kunming 10
Tianjin 10
Washington 10
Zanjan 10
Zhengzhou 9
Amsterdam 7
Bologna 7
Chicago 7
Hebei 7
Pisa 7
Hangzhou 6
Lappeenranta 6
Los Angeles 6
Modena 6
Salerno 6
San Francisco 6
Shenyang 6
Stockholm 6
Turin 6
Aachen 5
Dallas 5
Falkenstein 5
Kilburn 5
Lancaster 5
Lugo 5
Melbourne 5
Munich 5
Palermo 5
Perugia 5
Pistoia 5
Sesto Fiorentino 5
Toronto 5
Cagliari 4
Changsha 4
Colle di Val d'Elsa 4
Cosenza 4
Delhi 4
Enna 4
Falls Church 4
Figline Valdarno 4
Hounslow 4
Jinan 4
Leawood 4
Livorno 4
Lodi 4
Madrid 4
Montevarchi 4
Mumbai 4
Ningbo 4
Perth 4
Scandicci 4
Trento 4
Udine 4
Altopascio 3
Totale 7.484
Salva come PNG Salva come JPEG
Nome #
Small papillary thyroid carcinoma with minimal extrathyroidal extension should be managed as ATA low-risk tumor 229
Blockade of the programmed death ligand 1 (PD-L1) as potential therapy for anaplastic thyroid cancer 227
G-protein coupled receptors (GPCRs) in the treatment of diabetes: Current view and future perspectives 215
Nodules in autoimmune thyroiditis are associated with increased risk of thyroid cancer in surgical series but not in cytological series: evidence for selection bias 204
Obesity Does Not Modify the Risk of Differentiated Thyroid Cancer in a Cytological Series of Thyroid Nodules 202
Reference range of serum calcitonin in pediatric population 195
Chronic lymphocytic thyroiditis (CLT) has a positive prognostic value in papillary thyroid cancer (PTC) patients: the potential key role of Foxp3+ T lymphocytes 194
CONUT Score: A New Tool for Predicting Prognosis in Patients with Advanced Thyroid Cancer Treated with TKI 186
Post-surgical thyroid ablation with low or high radioiodine activities results in similar outcomes in intermediate risk differentiated thyroid cancer patients 185
Rare POMC Mutation in a Patient With Myotonic Dystrophy Type 1 and Adrenocorticotropin Hyperresponse to Corticotropin-Releasing Hormone 181
MicroRNA expression profile of thyroid nodules in fine-needle aspiration cytology: a confirmatory series 169
FASTING ENHANCES TKI EFFICACY ON THYROID CANCER CELLS 165
Acute exogenous TSH administration stimulates leptin secretion in vivo. 162
Approach to and treatment of differentiated thyroid carcinoma 158
DIO2 Thr92Ala reduces deiodinase-2 activity and serum-T3 levels in thyroid-deficient patients 158
Clinical significance of type 2 iodothyronine deiodinase polymorphism 155
Large-scale screening of organ specific autoantibodies in patients with autoimmune thyroid diseases 147
Lack of association between urinary iodine excretion and successful thyroid ablation in thyroid cancer patients. 145
Medullary thyroid carcinoma. 140
Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes. 139
One month weight loss predicts the efficacy of liraglutide in obese patients: Data from a single center 138
Long-term efficacy of modified-release recombinant human thyrotropin augmented radioiodine therapy for benign multinodular goiter: results from a multicenter, international, randomized, placebo-controlled, dose-selection study 137
Variants in MCT10 protein do not affect FT3 levels in athyreotic patients 137
Delayed risk stratification, to include the response to initial treatment (surgery and radioiodine ablation), has better outcome predictivity in differentiated thyroid cancer patients 136
Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. 135
null 135
Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up 133
Reappraisal of the indication for radioiodine thyroid ablation in differentiated thyroid cancer patients 130
null 126
Role of age at diagnosis in defining potential familial nonmedullary thyroid cancer in kindreds with two affected members 124
Androgen Deprivation Therapy for Prostatic Cancer in Patients With Torsades de Pointes 119
Long-Term Clinical Outcome in Familial and Sporadic Papillary Thyroid Carcinoma 117
Effects of Acute Recombinant Human TSH on Serum Ghrelin Levels 111
Molecular signature of indeterminate thyroid lesions: Current methods to improve fine needle aspiration cytology (FNAC) diagnosis 107
HABP2 G534E variation in familial non-medullary thyroid cancer: an Italian series 103
Screening and detecting significant liver fibrosis in patients with NAFLD: A practical approach using non-invasive tests 103
New insight in the follow-up strategies of differentiated thyroid cancer 99
Dual energy CT in gland tumors: a comprehensive narrative review and differential diagnosis 99
Prospective Validation of ATA and ETA Sonographic Pattern Risk of Thyroid Nodules Selected for FNAC 98
Eif1ax c.338-2a>t splice site mutation in a patient with trabecular adenoma and cytological indeterminate lesion 97
BROX haploinsufficiency in familial nonmedullary thyroid cancer 96
Modified-release recombinant human TSH (MRrhTSH) augments the effect of (131)I therapy in benign multinodular goiter: results from a multicenter international, randomized, placebo-controlled study. 95
Indication for radioiodine remnant ablation in differentiated thyroid cancer patients: does 2018 Italian consensus change anything? 94
Calcitonin Levels in Thyroid Disease Are Not Affected by Autoimmune Thyroiditis or Differentiated Thyroid Carcinoma 94
Preliminary results from whole-genome expression analysis in patients with secondary adrenal insufficiency treated with modified-release hydrocortisone 91
RET/PTC3 rearrangement and thyroid differentiation gene analysis in a struma ovarii fortuitously revealed by elevated serum thyroglobulin concentration 91
Validation of American Thyroid Association Ultrasound Risk-Adapted Approach for Repeating Cytology in Benign Thyroid Nodules 90
8th edition of the AJCC/TNM staging system of thyroid cancer: What to expect (ITCO#2) 89
Should familial disease be considered as a negative prognostic factor in micropapillary thyroid carcinoma? 88
Baseline serum TSH levels predict the absence of thyroid dysfunction in cancer patients treated with immunotherapy 88
Autoimmune thyroid diseases are more common in patients with prolactinomas: a retrospective case–control study in an Italian cohort 84
Nodular Thyroid Disease in the Era of Precision Medicine 83
The use of ultrasensitive thyroglobulin assays reduces but does not abolish the need for TSH stimulation in patients with differentiated thyroid carcinoma. 80
Alteration of Serum Proteome in Levo-Thyroxine-Euthyroid Thyroidectomized Patients 77
Long-term Effects of Radioiodine in Toxic Multinodular Goiter: Thyroid Volume, Function, and Autoimmunity 76
null 75
Response Letter to the Editor from Edmundo Avila-Hipolito: "Long-term effects of radioiodine in toxic multinodular goitre: thyroid volume, function and autoimmunity" 73
Familial non-medullary thyroid cancer: a critical review 73
A comparison of 1850 (50 mCi) and 3700 MBq (100 mCi) 131-iodine administered doses for recombinant thyrotropin-stimulated postoperative thyroid remnant ablation in differentiated thyroid cancer 72
Permanent diabetes insipidus in a patient with mesothelioma treated with immunotherapy 69
Real-world efficacy and safety of lenvatinib: data from a compassionate use in the treatment of radioactive iodine-refractory differentiated thyroid cancer patients in Italy 67
Ablation of thyroid residues with 30 mCi 131I: A comparison in thyroid cancer patients prepared with recombinant human TSH or thyroid hormone withdrawal 67
Transient hypogonadism is associated with heart rate-corrected QT prolongation and torsades de pointes risk during active systemic inflammation in men 66
Controlling Nutritional Status (CONUT) Score and Micronutrient Deficiency in Bariatric Patients: Midterm Outcomes of Roux-en-Y Gastric Bypass Versus One Anastomosis Gastric Bypass/Mini Gastric Bypass 66
Changes in both size and cytological features of thyroid nodule after levothyroxine treatment 65
Features and outcome of differentiated thyroid carcinoma associated with Graves’ disease: results of a large, retrospective, multicenter study 65
Real-world performance of ATA risk estimates in predicting 1-year DTC outcomes: A prospective multicenter study of 2000 patients (ITCO Study #3) 64
Thr92Ala polymorphism in the type 2 deiodinase gene: an evolutionary perspective 64
Prediction of disease status by recombinant human TSH-stimulated serum Tg in the postsurgical follow-up of differentiated thyroid carcinoma 62
Limited value of repeat recombinant human thyrotropin (rhTSH)-stimulated thyroglobulin testing in differentiated thyroid carcinoma patients with previous negative rhTSH-stimulated thyroglobulin and undetectable basal serum thyroglobulin levels 60
Vemurafenib may overcome TNF-related apoptosis-inducing ligand (TRAIL) resistance in anaplastic thyroid cancer cells 60
Monitoraggio del nodulo tiroideo benigno in accordo con la classe di rischio ecografica 59
Attention deficit and hyperactivity disorders in the offspring of mothers exposed to mild-moderate iodine deficiency: A possible novel iodine deficiency disorder in developed countries 59
Pilot study on the impact of polymorphisms linked to multi-kinase inhibitor metabolism on lenvatinib side effects in patients with advanced thyroid cancer 58
A case of papillary thyroid cancer without aggressive histological features with nodal metastases detected during follow-up in a younger patients 58
Incidental findings of anti-mitochondrial antibodies without evidence of Primary Biliary Cholangitis. 58
Pregnancy-associated plasma protein A mRNA expression as a marker for differentiated thyroid cancer: results from a "surgical" and a "cytological" series 56
Differentiated thyroid cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up 55
Diagnostic and therapeutic use of recombinant human TSH (rhTSH) in differentiated thyroid cancer 55
Recombinant human thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma 55
European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium 55
Risk of second malignant neoplasm in familial non-medullary thyroid cancer patients 51
Differentiated thyroid cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up 50
Silent thyroiditis following vaccination against COVID-19: report of two cases 49
RET/PTC3 rearrangement and thyroid differentiation gene analysis in a struma ovarii fortuitously revealed by elevated serum thyroglobulin concentration 49
Lean body mass is a major determinant of levothyroxine dosage in the treatment of thyroid diseases 48
Influence of human body composition on serum peak thyrotropin (TSH) after recombinant human TSH administration in patients with differentiated thyroid carcinoma 47
Failure to use measurement of megalin secretory components complexed with serum thyroglobulin as a tool to identify metastases after surgery in papillary thyroid cancer 45
A case of papillary thyroid cancer without aggressive histological features with nodal metastyases in an older patients 43
Post-chernobyl increased prevalence of humoral thyroid autoimmunity in children and adolescents from a moderately iodine-deficient area in Russia 42
Video assisted prophylactic thyroidectomy and central compartment nodes clearance in two RET gene mutation adult carriers 42
Increased risk of maternal thyroid failure with pregnancy progression in an iodine deficient area with major iodine deficiency disorders 42
Radioiodine therapy in the different stages of differentiated thyroid cancer 41
Epidemiology of simultaneous medullary and papillary thyroid carcinomas (MTC/PTC): An Italian multicenter study 40
Short-term effectiveness of low-dose radioiodine ablative treatment of thyroid remnants after thyroidectomy for differentiated thyroid cancer 40
Thyroid cancer- A case-Based Approach 39
Medullary and papillary tumors are frequently associated in the same thyroid gland without evidence of reciprocal influence in their biologic behavior 38
Autosomal dominant familial neurohypophyseal diabetes insipidus caused by a novel missense mutation in AVP gene in a large Italian kindred 37
Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males 36
Screening of organ-specific autoantibodies in a large cohort of patients with autoimmune thyroid diseases. 34
Totale 9.705
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.430
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.430
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.313 0 0 77 202 88 118 144 157 138 105 49 235
2020/20212.106 55 213 67 206 187 285 114 330 153 266 115 115
2021/20221.375 120 110 112 147 78 87 38 51 81 151 168 232
2022/20231.815 111 219 223 202 132 369 80 125 174 71 56 53
2023/20242.037 69 51 164 125 141 422 684 81 43 42 45 170
2024/2025292 98 193 1 0 0 0 0 0 0 0 0 0
Totale 10.244